NCT05185011

Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function

A Phase I Clinical Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild Liver Insufficiency, Moderate Liver Insufficiency and Normal Liver Function

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Vigonvita Life Sciences · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The study aims to investigate and compare the effect of TPN171H on subjects with mild and moderate hepatic impairment compared to healthy subjects.

Conditions

• Erectile Dysfunction
• Pulmonary Arterial Hypertension

Interventions

Type	Name	Description
DRUG	TPN171H	10 mg TPN171H tablets，single dose

Timeline

• Start date: 2021-12-16
• Primary completion: 2022-02-06
• Completion: 2022-02-06
• First posted: 2022-01-11
• Last updated: 2022-03-23

Locations

1 site across 1 country: China